CleveMed Releases New eCrystal PSG Web Portal

Share Article

CleveMed announces launch of eCrystal PSG web portal, allowing physicians to seamlessly access sleep study information and share results with staff and a network of sleep specialists, providing convenience for patients, proper assessment for the provider, and cost benefits for the payer.

Home Sleep Testing, if conducted properly, can offer convenience, proper assessment, and cost benefits. In this next chapter in sleep medicine, it is critical to continue to rely on the expertise of sleep physicians to ensure proper study interpretation.

CleveMed, a leader in sleep disorders monitoring devices announces the launch of eCrystal PSG, its newest product. eCrystal PSG™ is a web portal that allows physicians to seamlessly access sleep study information and share results with other staff and specialists over a secured internet connection, creating an efficient method to detect and track sleep apnea. The web portal works hand-in-hand with a number of CleveMed home monitors like SleepView™, which records physiological data while the patient sleeps at home. Once the monitor is returned to the physician, data is uploaded to eCrystal PSG and sent to a sleep technologist for review and scoring. Via the web portal, ordering physicians can also connect with state-licensed sleep doctors for proper interpretation of the sleep study. With this product, CleveMed offers the widest range of portable sleep monitors in the market today strengthening its leading position in the market place.

“Testing for sleep apnea in the home, if conducted properly, can offer convenience for the patient, proper assessment for the provider, and cost benefit for the payer,” said Hani Kayyali, the president of CleveMed. "With the addition of the web portal, our breadth of products and services are poised to lead the way in the proper implementation of home healthcare for sleep disorders.”

“As we move forward into the next chapter in sleep medicine, it is critical that we continue to rely on the expertise of sleep physicians to ensure proper study interpretation,” said Dr. Mike Papsidero, CleveMed’s Chief Medical Officer. “CleveMed’s web technologies ensure great quality, convenience and connectivity to a network of sleep physicians, all of which improve patient care and maintain key advantages over the competition.”

Obstructive sleep apnea (OSA) is a disorder that prevents breathing during the night and affects more than 15 million patients. Although effective treatment exists, the vast majority of patients (80%) remain undiagnosed and untreated due to the expense and inconvenience of current testing methods. CleveMed’s family of portable sleep testing products effectively addresses this issue by facilitating evaluation in the home.

About CleveMed
CleveMed is pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities around the world. Cleveland Medical Devices Inc.'s mission is to develop, manufacture and market rehabilitation and monitoring products that improve quality of life and allow patients to leave the hospital earlier, thus lowering total health care costs. For more information, please visit http://www.CleveMed.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amy Rickard
CleveMed
2163615409
Email >
Visit website

Media